Arca
Skip to content

Warning Letter to Rontis Hellas S.A.

Medical Devices. See Rontis Hellas S.A.'s company page or this site's inspections.

On Feb 26, 2026, FDA's CDRH sent Rontis Hellas S.A. a warning letter.

  • Letter date: Feb 26, 2026
  • Issued by: CDRH
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

Dear Mr. Anastasios Politopoulos:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS #695160 dated October 28, 2024). Based on our evaluation of the evidence provided in your Warning Letter response #5 (received by FDA on December 31, 2025), it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely, /S/ for Bram Zuckerman, MD Director OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

CC: Jessica Osward-McLeod Nipro Medical Corporation 3150 NW 107th Ave. Miami, Florida 33172, USA jessicao@nipromed.com

The Firm's Other Letters

Same company or the same FDA site, newest first

Record

Recipient
Mr. Anastasios Politopoulos
FDA site ID (FEI)
3011142981
Cited
—

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.